Objective: To construct nomograms of orbital diameters in early pregnancy by transvaginal sonography. Design: A prospective cross-sectional study. Methods: The study was performed on 923 consecutive normal singleton pregnancies from 10 to 16 weeks of gestation, using transvaginal high-resolution ultrasound technique. The interocular distance (IOD), binocular distance (BOD), as well as the orbital diameter (OD) at each gestational age (GA, days), were recorded. The distribution of the residuals for the different orbital measurements are also described. Results: The increase in each of the ocular parameters studied could be accurately described by a linear model. The regression equation for orbital measurements as a function of GA was: for IOD, y = 0.153 GA (days) – 6.73 (r2 = 0.82); for BOD, y = 0.387 GA (days) – 16.85 (r2 = 0.80), and for OD, y = 0.132 GA (days) – 6.435 (r2 = 0.79). IOD and OD demonstrate a normal distribution of the residuals with uniform variance. Conclusion: The presented data obtained in early pregnancy by transvaginal scan offer normative measurements of the orbital diameter which may be useful in the prenatal diagnosis of congenital syndromes that include, among other manifestations, orbit maldevelopment and growth disturbances.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.